July 23, 2019 / 5:17 AM / 4 months ago

Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu

PARIS, July 23 (Reuters) - French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the 'Tamiflu' product in the United States.

The deal will give Sanofi exclusive U.S. over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.

"This is a strategic and important transaction for us as we strive to continually bring innovations to the market," said Alan Main, executive vice president of Sanofi's consumer healthcare division, in a statement. (Reporting by Sudip Kar-Gupta; Editing by Subhranshu Sahu)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below